Zura Bio Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Zura Bio stock has a consensus rating of "Strong Buy" and an average price target of $15.67. The average 1-year stock price forecast is 360.88% higher than the current stock price, while the lowest is $11 (+223.53%) and the highest is $26 (+664.71%).

Price Target: $15.67 (+360.88%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$11	$15.67	$15	$26
Change	+223.53%	+360.88%	+341.18%	+664.71%

Analyst Ratings

The average analyst rating for Zura Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	5	5	6	6	6	6
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Martin Fan Wedbush	Wedbush	Buy Maintains $15	Buy	Maintains	$15	+341.18%	May 8, 2026
Yatin Suneja Guggenheim	Guggenheim	Buy Maintains $15	Buy	Maintains	$15	+341.18%	May 8, 2026
Daniil Gataulin Chardan Capital	Chardan Capital	Buy Reiterates $4.89 → $11	Buy	Reiterates	$4.89 → $11	+223.53%	May 7, 2026
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $26	Buy	Maintains	$26	+664.71%	Apr 1, 2026
Justin Kim Oppenheimer	Oppenheimer	Buy Reiterates $15	Buy	Reiterates	$15	+341.18%	Mar 20, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

12.50M

EPS This Year

-0.64

from -1.06

EPS Next Year

-0.22

from -0.64

Fiscal Year	FY 2022	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Mar 31, 2022	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-
Operating Income	-46.91M	-29.63M	-62.64M	-55.19M	-75.25M	-93.51M
Net Income	-46.91M	-28.08M	-60.36M	-52.40M	-68.65M	-90.21M
EPS	-	-	-	-	-1.06	-0.64
Free Cash Flow	-	-	-25.08M	-24.76M	-42.52M	-63.00M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.64
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-